GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » PS Ratio

Awakn Life Sciences (Awakn Life Sciences) PS Ratio : 1.62 (As of Apr. 30, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Awakn Life Sciences's share price is $0.11. Awakn Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2023 was $0.07. Hence, Awakn Life Sciences's PS Ratio for today is 1.62.

The historical rank and industry rank for Awakn Life Sciences's PS Ratio or its related term are showing as below:

AWKNF' s PS Ratio Range Over the Past 10 Years
Min: 0.66   Med: 10.87   Max: 3000
Current: 1.97

During the past 3 years, Awakn Life Sciences's highest PS Ratio was 3000.00. The lowest was 0.66. And the median was 10.87.

AWKNF's PS Ratio is ranked better than
81.27% of 993 companies
in the Biotechnology industry
Industry Median: 8.99 vs AWKNF: 1.97

Awakn Life Sciences's Revenue per Sharefor the three months ended in Oct. 2023 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2023 was $0.07.

During the past 12 months, the average Revenue per Share Growth Rate of Awakn Life Sciences was 405.60% per year.

Back to Basics: PS Ratio


Awakn Life Sciences PS Ratio Historical Data

The historical data trend for Awakn Life Sciences's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences PS Ratio Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23
PS Ratio
- 185.45 5.68

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.33 5.68 4.44 2.89 2.42

Competitive Comparison of Awakn Life Sciences's PS Ratio

For the Biotechnology subindustry, Awakn Life Sciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's PS Ratio distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's PS Ratio falls into.



Awakn Life Sciences PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Awakn Life Sciences's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.11/0.068
=1.62

Awakn Life Sciences's Share Price of today is $0.11.
Awakn Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Awakn Life Sciences  (OTCPK:AWKNF) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Awakn Life Sciences PS Ratio Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (Awakn Life Sciences) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines